Although conflicting results were reported that SOCS2 expression was upregulated in prostate cancer45, 46, these findings provide insights into the role of SOCS2 in tumor suppression and highlight the potential usefulness of SOCS2 as a prognostic prediction biomarker. The gene discussed is SOCS2; the disease is neoplasm.